Answers are grounded in this paper and cite their sources.
Liver disease is one of the major health problems in manycountries. Mesenchymal Stem cells have opened a new approach todeal with liver fibrosis. Improvement of bone marrow derivedmesenchymal stem cellshoming after systemic injection ofdisintegrin/like domain purified from Egyptian horned Cerastescerastes crude venomwhichwas shown byprevious study. This workwas designed to investigate the possible mechanism of disintegrin/likedomainin mesenchymal stem cells homing to fibrotic liver of CCl4treated mice. Quantitative gene expression was performed for stromalcell-derived factor-1 to study homing of bone marrow derivedmesenchymal stem cells, transforming growth factor beta 1 to studybone marrow derived mesenchymal stem cellshoming andregeneration of liver cells and hepatocyte growth factor to studyregeneration of liver cells in CCl4 induced liver injury in white albinomice. It was found that disintegrin/like domaincould increase homingofbone marrow derived mesenchymal stem cells as showed by thesignificant increase in liver stromal cell-derived factor -1 geneexpression, transforming growth factor beta 1 as well as hepatocytegrowth factor genes expression compared to the non disintegrin/likedomaintreated CCl4 group.
No takes yet. Share an insight, caveat, or question.
Darwish et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: